Conflict of interest declaration: Rosaline Quinlivan

Roles in: Neuromuscular Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
Yes - Genzyme, PTC bio, Santhera

c) Fees for organising education?
Yes - Genzyme, Santhera, PTC bio

d) Funds for research?
Yes - European Union, Muscular Dystrophy UK, National Brain appeal, AGSDUK

e) Funds for a member of staff?
Yes - PhD students, Muscular Dystrophy UK and European Union

f) Fees for consulting?
Yes - PTC bio, Santhera, Sarepta

g) Royalty payments?
Yes - Oxford University Press book entitled: Duchenne Muscular Dystrophy F Muntoni, A Emery, R Quinlivan (very small amount)

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
No